Junaid Khan

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Edwards
    Topic: 
    Valvular heart disease
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Medtronic
    Topic: 
    Blood conservation
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Angiodynamics
    Topic: 
    Management of endocarditis
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Atricure
    Topic: 
    Management of Afib
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant
    Ineligible company: 
    Abbot
    Topic: 
    Cardiomyopathy
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Edwards
    Topic: 
    Valvular Heart disease
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Medtronic
    Topic: 
    Blood conversation
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Angiodynamics
    Topic: 
    Management of endocarditis
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Atricure
    Topic: 
    Management of Afib
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Speaker
    Ineligible company: 
    Abbot
    Topic: 
    Cardiomyopathy
    Date added: 
    06/01/2023
    Mitigation strategy: 
    Peer review
    Relationship end date: 
    06/01/2026
    Date reviewed: 
    10/02/2023
Return to 0210_ABSMC_When Surgery Makes Sense for Asymptomatic Valvular Disease_Live